Song, Eric
Mao, Tianyang
Dong, Huiping
Boisserand, Ligia Simoes Braga
Antila, Salli
Bosenberg, Marcus
Alitalo, Kari
Thomas, Jean-Leon
Iwasaki, Akiko
Article History
Received: 16 January 2019
Accepted: 21 November 2019
First Online: 15 January 2020
Change Date: 26 January 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-021-03204-z
Competing interests
: A.I., E.S. and J.-L.T. have filed a patent related to the manuscript as inventors (application number, US 62/768,390; status of application, provisional; specific aspect of manuscript covered in patent application, manipulation of meningeal lymphatic vasculature for brain and CNS tumour therapy. K.A. is an inventor on several patents that relate to VEGF-C. He and his wife currently have no income, stock or other benefits from companies that are related to the manuscript. Helsinki University is a shareholder in companies that are related to the use of VEGF-C. M.B. is a consultant for Eli Lilly and Company.